Nautilus Biotechnology, Inc. financial data

Symbol
NAUT on Nasdaq
Location
Seattle, WA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1603% % -13%
Debt-to-equity 19% % 17%
Return On Equity -34% % -8.9%
Return On Assets -28% % -6.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 126,564,473 shares 0.33%
Common Stock, Shares, Outstanding 126,469,610 shares 0.29%
Entity Public Float $35,800,000 USD -68%
Common Stock, Value, Issued $13,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 126,256,583 shares 0.66%
Weighted Average Number of Shares Outstanding, Diluted 126,256,583 shares 0.66%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $41,110,000 USD -19%
General and Administrative Expense $25,727,000 USD -17%
Nonoperating Income (Expense) $7,836,000 USD -27%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $59,001,000 USD 17%
Earnings Per Share, Basic -0.47 USD/shares 16%
Earnings Per Share, Diluted -0.47 USD/shares 16%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $12,388,000 USD -55%
Cash, Cash Equivalents, and Short-term Investments $103,400,000 USD -20%
Assets, Current $105,963,000 USD -20%
Property, Plant and Equipment, Net $3,457,000 USD -15%
Operating Lease, Right-of-Use Asset $27,773,000 USD -1.7%
Other Assets, Noncurrent $1,180,000 USD 0%
Assets $191,112,000 USD -21%
Accounts Payable, Current $943,000 USD -4.5%
Employee-related Liabilities, Current $2,514,000 USD 87%
Liabilities, Current $7,952,000 USD 4.2%
Operating Lease, Liability, Noncurrent $26,187,000 USD -0.74%
Liabilities $34,139,000 USD 0.37%
Accumulated Other Comprehensive Income (Loss), Net of Tax $243,000 USD 326%
Retained Earnings (Accumulated Deficit) $332,020,000 USD -22%
Stockholders' Equity Attributable to Parent $156,973,000 USD -25%
Liabilities and Equity $191,112,000 USD -21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,937,000 USD 14%
Net Cash Provided by (Used in) Financing Activities $18,000 USD -93%
Net Cash Provided by (Used in) Investing Activities $19,511,000 USD -13%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 126,469,610 shares 0.29%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,592,000 USD -12%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13,390,000 USD -53%
Deferred Tax Assets, Valuation Allowance $93,398,000 USD 19%
Deferred Tax Assets, Gross $100,884,000 USD 17%
Operating Lease, Liability $30,019,000 USD -1.5%
Depreciation $1,700,000 USD -15%
Payments to Acquire Property, Plant, and Equipment $219,000 USD -66%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $58,815,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid $38,233,000 USD -2.9%
Property, Plant and Equipment, Gross $11,578,000 USD 9.1%
Operating Lease, Liability, Current $3,832,000 USD -6.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,889,000 USD 0.22%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,264,000 USD -4.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure -1.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,214,000 USD -7.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,540,000 USD -5.1%
Deferred Tax Assets, Operating Loss Carryforwards $56,649,000 USD 73%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200,000,000 shares 0%
Unrecognized Tax Benefits $3,209,000 USD 2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,310,000 USD 8.5%
Operating Lease, Payments $1,800,000 USD 5.9%
Additional Paid in Capital $488,737,000 USD 1.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $7,486,000 USD -1%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%